All resources

Academic training posts offer paediatricians the opportunity to do crucial research in child health. Take a look at our guidance and links to further resources.

Following the known harms of valproate in pregnancy, MHRA released a report looking into the safety data for epilepsy medicines during pregnancy.

The page highlights examples of good practice from across the UK of effective transition from children's to adults' health services.

The BPSU has facilitated research into over 100 rare conditions. In many instances, the findings have had an immense influence over decisions relating to the condition and patient. Read case studies on the impact of BPSU's research below.

The British Paediatric Surveillance Unit (BPSU) welcomes applications from clinicians and researchers who wish to carry out national surveillance on rare childhood diseases.

The Royal College of Paediatrics and Child Health and British Paediatric Neurology Association has developed this Q&A in light of recent developments in this area. It advises on the legality and safety of cannabis-based products and considers the evidence base for their potential harms and benefits.

Doctors with prior training from outside a GMC (General Medical Council) approved programme, and who had not obtained the EU minimum time in GMC approved posts before receiving their outcome 6 ARCP, may have entered the Specialist Register through the Combined Programme certification.

As always, we're supporting paediatric trainees in the UK. As we continue in this extremely challenging period, we provide some guidance on how trainees can continue to gain valuable capabilities around the curriculum with examples and practical tips.

Since March 2020 the COVID-19 pandemic has caused unprecedented disruption to training and assessment in paediatrics in the UK as well as significant stresses to everyone's working and personal lives. We hope that, two years on, we are beginning to return to normal or at least to readjust to a new n...

This clinical framework is intended to provide a structure for the investigation, transfer and management of children with novel non-A-E acute hepatitis in the context of an emergence of a novel disease. The recommendations within this guidance are based on existing principles of management of ac...